| MeSH term | MeSH ID | Detail |
|---|---|---|
| Diabetic Nephropathies | D003928 | 39 associated lipids |
| Diabetic Neuropathies | D003929 | 5 associated lipids |
| Diarrhea | D003967 | 32 associated lipids |
| Dilatation, Pathologic | D004108 | 5 associated lipids |
| Disease Susceptibility | D004198 | 12 associated lipids |
| Emphysema | D004646 | 1 associated lipids |
| Encephalitis | D004660 | 15 associated lipids |
| Endocrine System Diseases | D004700 | 4 associated lipids |
| Endometriosis | D004715 | 29 associated lipids |
| Eye Neoplasms | D005134 | 2 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Pivonka P et al. | Model structure and control of bone remodeling: a theoretical study. | 2008 | Bone | pmid:18514606 |
| Gomes SA et al. | RANKL is a mediator of bone resorption in idiopathic hypercalciuria. | 2008 | Clin J Am Soc Nephrol | pmid:18480302 |
| Qin H and Yang FS | Calcitonin may be a useful therapeutic agent for osteoclastogenesis syndromes involving premature eruption of the tooth. | 2008 | Med. Hypotheses | pmid:18023993 |
| You L et al. | Osteocytes as mechanosensors in the inhibition of bone resorption due to mechanical loading. | 2008 | Bone | pmid:17997378 |
| Secchiero P et al. | Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells. | 2008 | Blood | pmid:18000166 |
| Haynes D et al. | Modulation of RANKL and osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis in response to disease-modifying antirheumatic drug treatment and correlation with radiologic outcome. | 2008 | Arthritis Rheum. | pmid:18576301 |
| Coleman R et al. | Bone markers and their prognostic value in metastatic bone disease: clinical evidence and future directions. | 2008 | Cancer Treat. Rev. | pmid:18579314 |
| Kearns AE et al. | Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. | 2008 | Endocr. Rev. | pmid:18057140 |
| Escobar-Morreale HF et al. | Serum osteoprotegerin concentrations are decreased in women with the polycystic ovary syndrome. | 2008 | Eur. J. Endocrinol. | pmid:18579554 |
| Shroff RC et al. | The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis. | 2008 | Nephrol. Dial. Transplant. | pmid:18463323 |
| Lee AZ et al. | Stimulation of cytokines in osteoblasts cultured on enamel matrix derivative. | 2008 | Oral Surg Oral Med Oral Pathol Oral Radiol Endod | pmid:18585627 |
| Ma Y and Ye S | [The expression of receptor activator nuclear factor-kappaB ligand and osteoprotegerin in cholesteatoma]. | 2008 | Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi | pmid:18589796 |
| Dinçel E et al. | Hip fracture risk and different gene polymorphisms in the Turkish population. | 2008 | Clinics (Sao Paulo) | pmid:18925325 |
| de Amorim FP et al. | Imbalance of RANK, RANKL and OPG expression during tibial fracture repair in diabetic rats. | 2008 | J. Mol. Histol. | pmid:18592139 |
| Kamiya N et al. | BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway. | 2008 | Development | pmid:18927151 |
| Bu G et al. | Breast cancer-derived Dickkopf1 inhibits osteoblast differentiation and osteoprotegerin expression: implication for breast cancer osteolytic bone metastases. | 2008 | Int. J. Cancer | pmid:18546262 |
| Andrade FR et al. | Expression of bone resorption regulators (RANK, RANKL, and OPG) in odontogenic tumors. | 2008 | Oral Surg Oral Med Oral Pathol Oral Radiol Endod | pmid:18928898 |
| Makihira S et al. | Impact of the microgravity environment in a 3-dimensional clinostat on osteoblast- and osteoclast-like cells. | 2008 | Cell Biol. Int. | pmid:18550393 |
| Ralston SH | Pathogenesis of Paget's disease of bone. | 2008 | Bone | pmid:18672105 |
| Cochran DL | Inflammation and bone loss in periodontal disease. | 2008 | J. Periodontol. | pmid:18673012 |
| Wang Y et al. | Chicken receptor activator of nuclear factor-kappaB ligand induces formation of chicken osteoclasts from bone marrow cells and also directly activates mature osteoclasts. | 2008 | Poult. Sci. | pmid:18931186 |
| Huang SH et al. | [Guling tablets promotes the proliferation and mineralization and regulates OPG/RANKL/M-CSF expression of osteoblasts via the p38 MAPK pathway in vitro]. | 2008 | Nan Fang Yi Ke Da Xue Xue Bao | pmid:18676248 |
| De Toni EN et al. | OPG is regulated by beta-catenin and mediates resistance to TRAIL-induced apoptosis in colon cancer. | 2008 | Clin. Cancer Res. | pmid:18676739 |
| Haaber J et al. | Myeloma cell expression of 10 candidate genes for osteolytic bone disease. Only overexpression of DKK1 correlates with clinical bone involvement at diagnosis. | 2008 | Br. J. Haematol. | pmid:18005268 |
| Armstrong AP et al. | RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes. | 2008 | Prostate | pmid:18008334 |
| Yang J et al. | HMGB1 is a bone-active cytokine. | 2008 | J. Cell. Physiol. | pmid:17786958 |
| Sipos W et al. | Strategies for novel therapeutic approaches targeting cytokines and signaling pathways of osteoclasto- and osteoblastogenesis in the fight against immune-mediated bone and joint diseases. | 2008 | Curr. Med. Chem. | pmid:18220768 |
| Papadopouli AE et al. | Role of OPG/RANKL/RANK axis on the vasculature. | 2008 | Histol. Histopathol. | pmid:18228207 |
| Kadoglou NP et al. | The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerability. | 2008 | J. Vasc. Surg. | pmid:18178454 |
| Yaturu S et al. | Relationship of elevated osteoprotegerin with insulin resistance, CRP, and TNF-alpha levels in men with type 2 diabetes. | 2008 | Cytokine | pmid:18789716 |
| Findlay D et al. | Circulating RANKL is inversely related to RANKL mRNA levels in bone in osteoarthritic males. | 2008 | Arthritis Res. Ther. | pmid:18182105 |
| Hikosaka Y et al. | The cytokine RANKL produced by positively selected thymocytes fosters medullary thymic epithelial cells that express autoimmune regulator. | 2008 | Immunity | pmid:18799150 |
| Kimura M et al. | Bisphosphonate treatment increases the size of the mandibular condyle and normalizes growth of the mandibular ramus in osteoprotegerin-deficient mice. | 2008 | Calcif. Tissue Int. | pmid:18183447 |
| Bowsher RR and Sailstad JM | Insights in the application of research-grade diagnostic kits for biomarker assessments in support of clinical drug development: bioanalysis of circulating concentrations of soluble receptor activator of nuclear factor kappaB ligand. | 2008 | J Pharm Biomed Anal | pmid:18977625 |
| Johnson KA et al. | Transglutaminase 2 is central to induction of the arterial calcification program by smooth muscle cells. | 2008 | Circ. Res. | pmid:18202319 |
| Castellino G et al. | Is there any role for tumour necrosis factor related apoptosis inducing ligand-osteoprotegerin (TRAIL-OPG) interaction in rheumatoid arthritis? | 2008 | Ann. Rheum. Dis. | pmid:18621972 |
| Schwartz Z et al. | Effect of micrometer-scale roughness of the surface of Ti6Al4V pedicle screws in vitro and in vivo. | 2008 | J Bone Joint Surg Am | pmid:18978418 |
| Yen ML et al. | TNF-related apoptosis-inducing ligand (TRAIL) induces osteoclast differentiation from monocyte/macrophage lineage precursor cells. | 2008 | Mol. Immunol. | pmid:18206242 |
| Granchi D et al. | Paracrine inhibition of osteoblast differentiation induced by neuroblastoma cells. | 2008 | Int. J. Cancer | pmid:18623132 |
| Roato I et al. | Osteoclasts are active in bone forming metastases of prostate cancer patients. | 2008 | PLoS ONE | pmid:18978943 |
| Kurban S et al. | Receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin levels in multiple sclerosis. | 2008 | Mult. Scler. | pmid:18208894 |
| Baioni CS et al. | Analysis of the association of polymorphism in the osteoprotegerin gene with susceptibility to chronic kidney disease and periodontitis. | 2008 | J. Periodont. Res. | pmid:18624938 |
| Fernandes JC et al. | An active role for soluble and membrane intercellular adhesion molecule-1 in osteoclast activity in vitro. | 2008 | J. Bone Miner. Metab. | pmid:18979153 |
| Lossdörfer S et al. | Subculture affects the phenotypic expression of human periodontal ligament cells and their response to fibroblast growth factor-2 and bone morphogenetic protein-7 in vitro. | 2008 | J. Periodont. Res. | pmid:18624939 |
| Nakamura H et al. | Involvement of cell-cell and cell-matrix interactions in bone destruction induced by metastatic MDA-MB-231 human breast cancer cells in nude mice. | 2008 | J. Bone Miner. Metab. | pmid:18979165 |
| Kobayashi-Sakamoto M et al. | Role of alphav integrin in osteoprotegerin-induced endothelial cell migration and proliferation. | 2008 | Microvasc. Res. | pmid:18656492 |
| Wang J et al. | [Osteoprotegerin mRNA/receptor activator of NF-kappaB ligand mRNA expressions in bone tissues of glucocorticoid-induced osteonecrosis of the femoral head]. | 2008 | Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi | pmid:18979868 |
| Preusch MR et al. | Critical role of macrophages in glucocorticoid driven vascular calcification in a mouse-model of atherosclerosis. | 2008 | Arterioscler. Thromb. Vasc. Biol. | pmid:18787189 |
| Kannus P et al. | Fractures are not in genes. | 2008 | Lancet | pmid:18970970 |
| Wu L et al. | [Immunolocalization of receptor activator of NF-kappaB ligand and osteoprotegerin during mouse mandibular first molar eruption]. | 2008 | Zhonghua Kou Qiang Yi Xue Za Zhi | pmid:18788552 |
| Liang L et al. | Estrogen regulates expression of osteoprotegerin and RANKL in human periodontal ligament cells through estrogen receptor beta. | 2008 | J. Periodontol. | pmid:18771377 |
| Zhang H et al. | [Effect of recombinant human osteoprotegerin on osteoclasts stimulated by polyethylene particles]. | 2008 | Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi | pmid:18773818 |
| Hase H et al. | Coculture of osteoclast precursors with rheumatoid synovial fibroblasts induces osteoclastogenesis via transforming growth factor beta-mediated down-regulation of osteoprotegerin. | 2008 | Arthritis Rheum. | pmid:18975335 |
| Mikami S et al. | Serum osteoprotegerin as a screening tool for coronary artery calcification score in diabetic pre-dialysis patients. | 2008 | Hypertens. Res. | pmid:18716364 |
| Jorsal A et al. | Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy. | 2008 | Diabetologia | pmid:18719882 |
| Akinci B et al. | Serum osteoprotegerin is associated with carotid intima media thickness in women with previous gestational diabetes. | 2008 | Diabetes Res. Clin. Pract. | pmid:18722030 |
| Claudino M et al. | The broad effects of the functional IL-10 promoter-592 polymorphism: modulation of IL-10, TIMP-3, and OPG expression and their association with periodontal disease outcome. | 2008 | J. Leukoc. Biol. | pmid:18725394 |
| Hein GE et al. | sRANKL and OPG in serum and synovial fluid of patients with rheumatoid arthritis in comparison to non-destructive chronic arthritis. | 2008 | Rheumatol. Int. | pmid:18172654 |
| Lloyd SA et al. | Development of a low-dose anti-resorptive drug regimen reveals synergistic suppression of bone formation when coupled with disuse. | 2008 | J. Appl. Physiol. | pmid:18174391 |
| Cao Y et al. | The osterix transcription factor down-regulates interleukin-1 alpha expression in mouse osteosarcoma cells. | 2008 | Mol. Cancer Res. | pmid:18234967 |
| Del Fattore A et al. | Osteoclast receptors and signaling. | 2008 | Arch. Biochem. Biophys. | pmid:18237538 |
| de la Piedra C et al. | Osteoinductive effect of bone bank allografts on human osteoblasts in culture. | 2008 | J. Orthop. Res. | pmid:17853479 |
| Endres S et al. | Correlation of in vitro and in vivo results of vacuum plasma sprayed titanium implants with different surface topography. | 2008 | J Mater Sci Mater Med | pmid:17701309 |
| GarcÃa-Unzueta MT et al. | Association of the 163A/G and 1181G/C osteoprotegerin polymorphism with bone mineral density. | 2008 | Horm. Metab. Res. | pmid:18348083 |
| Pilichou A et al. | High levels of synovial fluid osteoprotegerin (OPG) and increased serum ratio of receptor activator of nuclear factor-kappa B ligand (RANKL) to OPG correlate with disease severity in patients with primary knee osteoarthritis. | 2008 | Clin. Biochem. | pmid:18355453 |
| Yamaguchi M et al. | Effect of zinc on gene expression in osteoblastic MC3T3-E1 cells: enhancement of Runx2, OPG, and regucalcin mRNA expressions. | 2008 | Mol. Cell. Biochem. | pmid:18327666 |
| Palazzuoli A et al. | Osteoprotegerin and B-type natriuretic peptide in non-ST elevation acute coronary syndromes: relation to coronary artery narrowing and plaques number. | 2008 | Clin. Chim. Acta | pmid:18328262 |
| Galusca B et al. | Constitutional thinness: unusual human phenotype of low bone quality. | 2008 | J. Clin. Endocrinol. Metab. | pmid:17956951 |
| Singh K et al. | An amperometric immunosensor for osteoproteogerin based on gold nanoparticles deposited conducting polymer. | 2008 | Biosens Bioelectron | pmid:18304799 |
| Qiang YW et al. | Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma. | 2008 | Blood | pmid:18305214 |
| Sangai T et al. | Roles of osteoclasts and bone-derived IGFs in the survival and growth of human breast cancer cells in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice. | 2008 | Clin. Exp. Metastasis | pmid:18307047 |
| Wang YL et al. | [Effect of estrogen-deficiency on expression of osteoprotegerin in alveolar bone: experiment with rats with periodontitis]. | 2008 | Zhonghua Yi Xue Za Zhi | pmid:19024546 |
| Vandooren B et al. | The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation. | 2008 | Arthritis Rheum. | pmid:18311801 |
| Fukada SY et al. | iNOS-derived nitric oxide modulates infection-stimulated bone loss. | 2008 | J. Dent. Res. | pmid:19029085 |
| Loddenkemper K and Burmester GR | What is the rank of RANKL in spondylarthritis? | 2008 | Arthritis Rheum. | pmid:18311809 |
| Vallés G et al. | Modulation of the cross-talk between macrophages and osteoblasts by titanium-based particles. | 2008 | Biomaterials | pmid:18313744 |
| Wang BL et al. | [Regulation of receptor activator of nuclear factor kappaB ligand and osteoprotegerin expression by prostaglandin E2 in osteoblastic-like cells]. | 2008 | Zhonghua Yi Xue Za Zhi | pmid:19062743 |
| Corallini F et al. | TRAIL and osteoprotegerin: a role in endothelial physiopathology? | 2008 | Front. Biosci. | pmid:17981533 |
| Yang Z et al. | [Effects of intermittent negative pressure on mRNA expression of osteoprotegerin and osteoprotegerin ligand in human BMSCs]. | 2008 | Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi | pmid:19068606 |
| Bakhireva LN et al. | Does osteoprotegerin or receptor activator of nuclear factor-kappaB ligand mediate the association between bone and coronary artery calcification? | 2008 | J. Clin. Endocrinol. Metab. | pmid:18319315 |
| Cross NA et al. | Phenotypic variations of TRAIL sensitivity in cloned populations of prostate cancer cells. | 2008 | J. Cell. Biochem. | pmid:18320583 |
| Anastasilakis AD et al. | Serum osteoprotegerin and RANKL are not specifically altered in women with postmenopausal osteoporosis treated with teriparatide or risedronate: a randomized, controlled trial. | 2008 | Horm. Metab. Res. | pmid:18275008 |
| Fan R et al. | [Expression of receptor activator of nuclear factor kappaB ligand and osteoprotegerin in chronic apical periodontitis]. | 2008 | Beijing Da Xue Xue Bao | pmid:18278135 |
| Charoenphandhu N et al. | Prolactin decreases expression of Runx2, osteoprotegerin, and RANKL in primary osteoblasts derived from tibiae of adult female rats. | 2008 | Can. J. Physiol. Pharmacol. | pmid:18432284 |
| Ominsky MS et al. | RANKL inhibition with osteoprotegerin increases bone strength by improving cortical and trabecular bone architecture in ovariectomized rats. | 2008 | J. Bone Miner. Res. | pmid:18433301 |
| Marini H et al. | OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. | 2008 | J. Bone Miner. Res. | pmid:18433304 |
| Miller RE et al. | RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis. | 2008 | Mol. Cancer Ther. | pmid:18606716 |
| Colvin L and Fallon M | Challenges in cancer pain management--bone pain. | 2008 | Eur. J. Cancer | pmid:18439817 |
| Zheng Y et al. | Bone resorption increases tumour growth in a mouse model of osteosclerotic breast cancer metastasis. | 2008 | Clin. Exp. Metastasis | pmid:18421566 |
| Tang XL et al. | [Effects of calcitriol on the expression of vitamin D receptor, RANKL and osteoprotegerin in human periodontal ligament cells]. | 2008 | Zhonghua Kou Qiang Yi Xue Za Zhi | pmid:19134349 |
| Stupphann D et al. | Intracellular and surface RANKL are differentially regulated in patients with ankylosing spondylitis. | 2008 | Rheumatol. Int. | pmid:18369625 |
| Kadoglou NP et al. | Intensive lipid-lowering therapy ameliorates novel calcification markers and GSM score in patients with carotid stenosis. | 2008 | Eur J Vasc Endovasc Surg | pmid:18395477 |
| Leibbrandt A and Penninger JM | RANK/RANKL: regulators of immune responses and bone physiology. | 2008 | Ann. N. Y. Acad. Sci. | pmid:19076348 |
| Tyrovola JB et al. | Root resorption and the OPG/RANKL/RANK system: a mini review. | 2008 | J Oral Sci | pmid:19106463 |
| Rausch-fan X et al. | Differentiation and cytokine synthesis of human alveolar osteoblasts compared to osteoblast-like cells (MG63) in response to titanium surfaces. | 2008 | Dent Mater | pmid:17467048 |
| Vallés G et al. | Rutile and titanium particles differentially affect the production of osteoblastic local factors. | 2008 | J Biomed Mater Res A | pmid:17607761 |
| Golledge J et al. | Relationship between CT anthropometric measurements, adipokines and abdominal aortic calcification. | 2008 | Atherosclerosis | pmid:17675038 |
| Galal N et al. | Effect of estrogen on bone resorption and inflammation in the temporomandibular joint cellular elements. | 2008 | Int. J. Mol. Med. | pmid:18506373 |
| Steinmetz M et al. | Differential profile of the OPG/RANKL/RANK-system in degenerative aortic native and bioprosthetic valves. | 2008 | J. Heart Valve Dis. | pmid:18512489 |
| Urban NH et al. | Effects of alpha/beta-androstenediol immune regulating hormones on bone remodeling and apoptosis in osteoblasts. | 2008 | J. Steroid Biochem. Mol. Biol. | pmid:18513951 |